/SOPH
SOPH Stock - SOPHiA GENETICS S.A.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$5.25+1.94%
+$0.10 (+1.94%) • Jan 13
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).40
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.76
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-4.8%upside
Target: $5.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SOPH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.20 – $5.30
TARGET (TP)$5.00
STOP LOSS$4.83
RISK/REWARD1:-0.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.11
52W High$5.54
52W Low$2.58
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $65.17M | $62.37M | $47.56M | $40.45M | $28.40M |
| Gross Profit | $43.94M | $42.91M | $31.25M | $25.22M | $17.69M |
| Gross Margin | 67.4% | 68.8% | 65.7% | 62.4% | 62.3% |
| Operating Income | $-66,568,000 | $-74,826,000 | $-87,823,000 | $-71,489,000 | $-37,387,000 |
| Net Income | $-62,493,000 | $-78,981,000 | $-87,449,000 | $-73,675,000 | $-39,339,000 |
| Net Margin | -95.9% | -126.6% | -183.9% | -182.1% | -138.5% |
| EPS | $-0.95 | $-1.22 | $-1.36 | $-1.33 | $-0.82 |
Company Overview
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SOPHBeat Rate
44%
Last 18 quarters
Avg Surprise
+11.2%
EPS vs Estimate
Beats / Misses
8/8
2 met exactly
Latest EPS
$-0.30
Q4 2025
EPS Surprise History
Q1 24
-48.0%
$-0.37vs$-0.25
Q2 24
+16.0%
$-0.21vs$-0.25
Q3 24
+17.9%
$-0.23vs$-0.28
Q4 24
-16.7%
$-0.28vs$-0.24
Q1 25
0.0%
$-0.23vs$-0.23
Q2 25
-23.8%
$-0.26vs$-0.21
Q3 25
+257.1%
$0.33vs$-0.21
Q4 25
-50.0%
$-0.30vs$-0.20
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Mar 3, 2026 | $-0.20 | — | — | — |
Q4 2025 | Nov 4, 2025 | $-0.20 | $-0.30 | -50.0% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $-0.21 | $0.33 | +257.1% | ✓ BEAT |
Q2 2025 | May 6, 2025 | $-0.21 | $-0.26 | -23.8% | ✗ MISS |
Q1 2025 | Mar 4, 2025 | $-0.23 | $-0.23 | 0.0% | = MET |
Q4 2024 | Nov 5, 2024 | $-0.24 | $-0.28 | -16.7% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $-0.28 | $-0.23 | +17.9% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $-0.25 | $-0.21 | +16.0% | ✓ BEAT |
Q1 2024 | Mar 5, 2024 | $-0.25 | $-0.37 | -48.0% | ✗ MISS |
Q4 2023 | Nov 7, 2023 | $-0.32 | $-0.21 | +34.4% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $-0.29 | $-0.33 | -13.8% | ✗ MISS |
Q2 2023 | May 9, 2023 | $-0.28 | $-0.31 | -10.7% | ✗ MISS |
Q1 2023 | Mar 7, 2023 | $-0.34 | $-0.22 | +35.3% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $-0.34 | $-0.36 | -5.9% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $-0.39 | $-0.39 | 0.0% | = MET |
Q2 2022 | May 10, 2022 | $-0.33 | $-0.40 | -21.2% | ✗ MISS |
Q1 2022 | Mar 15, 2022 | $-0.34 | $-0.33 | +2.9% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $-0.38 | $-0.35 | +7.9% | ✓ BEAT |
Q3 2021 | Sep 9, 2021 | $-0.39 | $-0.31 | +20.5% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about SOPH
What is SOPH's current stock price?
SOPHiA GENETICS S.A. (SOPH) is currently trading at $5.25 per share. The stock has moved +1.94% today.
What is the analyst price target for SOPH?
The average analyst price target for SOPH is $5.00, based on 1 analyst.
What sector is SOPHiA GENETICS S.A. in?
SOPHiA GENETICS S.A. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is SOPH's market cap?
SOPHiA GENETICS S.A. has a market capitalization of $0.35 billion, making it a small-cap company.
Does SOPH pay dividends?
No, SOPHiA GENETICS S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACIU
AC Immune S.A.
$3.70
Mkt Cap: $0.4B
AGL
Agilon Health, Inc.
$0.95
Mkt Cap: $0.4B
ANRO
Alto Neuroscience, Inc.
$16.50
Mkt Cap: $0.5B
CLLS
Cellectis S.A.
$4.25
Mkt Cap: $0.4B
DH
Definitive Healthcare Corp.
$2.47
Mkt Cap: $0.3B
LRMR
Larimar Therapeutics, Inc.
$3.33
Mkt Cap: $0.3B
NAKA
Kindly MD, Inc.
$0.46
Mkt Cap: $0.2B
NRC
National Research Corporation
$20.88
Mkt Cap: $0.5B
OPRX
OptimizeRx Corporation
$12.63
Mkt Cap: $0.2B
SLP
Simulations Plus, Inc.
$19.87
Mkt Cap: $0.4B
Explore stocks similar to SOPH for comparison